$CNFN
CFN Enterprises Inc. Stock $cnfn

$cnfn Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000109690623000855 Filed on April 17, 2023

Income Statement

Concept	2023 Q2	2022 Q4	2022
Revenue	$152.3K	$488.9K	$4.317M
YoY Change	-89.63%	-71.35%	36.73%
Cost Of Revenue	$47.48K	$801.4K	$6.512M
YoY Change	-97.76%	-69.06%	83.98%
Gross Profit	$104.8K	-$312.6K	-$2.195M
YoY Change	-116.16%	-64.64%	474.72%
Gross Profit Margin	68.82%	-63.93%	-50.83%
Selling, General & Admin	$1.703M	$853.0K	$2.642M
YoY Change	117.19%	-25.14%	-1.84%
% of Gross Profit	1624.86%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.831K	$402.5K	$1.612M
YoY Change	-99.3%	43.66%	321.06%
% of Gross Profit	2.7%
Operating Expenses	$1.703M	$853.0K	$6.158M
YoY Change	117.19%	-25.14%	128.81%
Operating Profit	-$1.598M	-$1.166M	-$8.452M
YoY Change	11.54%	-42.4%	175.04%
Interest Expense	$37.45K	-$429.0K	$694.4K
YoY Change	-64.69%	301.38%	-639.03%
% of Operating Profit
Other Income/Expense, Net	$142.6K	$30.43K	-$1.470M
YoY Change	-521.25%	-88.43%	-379.43%
Pretax Income	-$1.456M	-$6.031M	-$9.922M
YoY Change	-0.76%	-46.26%	-18.7%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.456M	-$6.071M	-$9.929M
YoY Change	-0.76%	-45.76%	-18.68%
Net Earnings / Revenue	-955.81%	-1241.84%	-229.98%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.04	-$0.16	-$0.30
COMMON SHARES
Basic Shares Outstanding	40.09M shares	36.73M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.048M	$12.47K	$12.47K
YoY Change	589.04%	-94.24%	-94.24%
Cash & Equivalents	$1.048M	$12.47K
Short-Term Investments		$0.00	$0.00
Other Short-Term Assets	$20.28K	$20.13K	$20.13K
YoY Change	-83.24%	-85.09%	-85.09%
Inventory	$0.00	$0.00	$0.00
Prepaid Expenses		$0.00
Receivables	$36.10K	$28.25K	$28.25K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.105M	$60.85K	$60.85K
YoY Change	188.44%	-90.66%	-90.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$47.91K	$53.57K	$163.9K
YoY Change	2.19%	27.15%	-97.17%
Goodwill		$0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Assets	$55.68K	$645.8K	$645.8K
YoY Change	18.77%	1432.9%	1432.9%
Total Long-Term Assets	$1.477M	$870.6K	$809.7K
YoY Change	-77.18%	-86.99%	-86.6%
TOTAL ASSETS
Total Short-Term Assets	$1.105M	$60.85K	$60.85K
Total Long-Term Assets	$1.477M	$870.6K	$809.7K
Total Assets	$1.477M	$870.6K	$870.6K
YoY Change	-77.18%	-86.99%	-86.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.318M	$2.358M	$2.358M
YoY Change	-3.64%	18.06%	18.06%
Accrued Expenses	$2.437M	$2.344M	$2.606M
YoY Change	29.32%	39.9%	39.07%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.795M	$3.088M	$3.088M
YoY Change	116.6%	39.12%	39.12%
Total Short-Term Liabilities	$9.459M	$8.864M	$8.864M
YoY Change	37.75%	21.49%	21.49%
LONG-TERM LIABILITIES
Long-Term Debt	$746.2K	$978.3K	$978.3K
YoY Change	-54.14%	-25.75%	-25.75%
Other Long-Term Liabilities	$223.8K	$200.8K	$200.8K
YoY Change	-60.46%	-57.76%	-57.76%
Total Long-Term Liabilities	$746.2K	$978.3K	$1.179M
YoY Change	-54.14%	-25.75%	-34.24%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.459M	$8.864M	$8.864M
Total Long-Term Liabilities	$746.2K	$978.3K	$1.179M
Total Liabilities	$10.43M	$10.04M	$10.04M
YoY Change	15.11%	10.5%	10.41%
SHAREHOLDERS EQUITY
Retained Earnings	-$61.12M	-$59.00M
YoY Change	18.17%	20.81%
Common Stock	$41.71K	$37.69K
YoY Change	23.32%	18.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$8.952M	-$9.172M	-$9.172M
YoY Change
Total Liabilities & Shareholders Equity	$1.477M	$870.6K	$870.6K
YoY Change	-77.18%	-86.99%	-86.99%

Cashflow Statement

Concept	2023 Q2	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$1.456M	-$6.071M	-$9.929M
YoY Change	-0.76%	-45.76%	-18.68%
Depreciation, Depletion And Amortization	$2.831K	$402.5K	$1.612M
YoY Change	-99.3%	43.66%	321.06%
Cash From Operating Activities	$22.00K	-$31.27K	-$1.419M
YoY Change	-101.74%	-64.89%	312.2%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$212.1K	$339.7K
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$608.3K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	$608.3K	-$212.1K	-$339.7K
YoY Change	-483.69%	562.93%	-1583.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$410.0K
YoY Change			583.33%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	399.3K	147.1K	$1.601M
YoY Change	-72.29%	34.55%	383.36%
NET CHANGE
Cash From Operating Activities	22.00K	-31.27K	-$1.419M
Cash From Investing Activities	608.3K	-212.1K	-$339.7K
Cash From Financing Activities	399.3K	147.1K	$1.601M
Net Change In Cash	1.030M	-96.21K	-$157.4K
YoY Change	6838.07%	722.31%	-1686.97%
FREE CASH FLOW
Cash From Operating Activities	$22.00K	-$31.27K	-$1.419M
Capital Expenditures	$0.00	$212.1K	$339.7K
Free Cash Flow	$22.00K	-$243.3K	-$1.759M
YoY Change	-101.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-52635
CY2022	dei	Entity Registrant Name EntityRegistrantName	CFN ENTERPRISES INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1559541
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	600 E. 8th STREET
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	WHITEFISH
CY2022	dei	Entity Address Country EntityAddressCountry	MT
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	59937
CY2022	dei	City Area Code CityAreaCode	(833)
CY2022	dei	Local Phone Number LocalPhoneNumber	420-2636
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	2074816	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40090664	shares
CY2022	dei	Auditor Name AuditorName	RBSM LLP
CY2022	dei	Auditor Location AuditorLocation	New York, NY
CY2022	dei	Auditor Firm AuditorFirmId	587
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12474	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	170015	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	20128	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	20014	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	28245	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	142271	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	0	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	157706	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	46516	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	0	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	115000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	60847	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	651522	usd
CY2022Q4	us-gaap	Investments Investments	0	usd
CY2021Q4	us-gaap	Investments Investments	200000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	53570	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5135996	usd
CY2022Q4	fil	Right Of Use Asset RightOfUseAsset	110321	usd
CY2021Q4	fil	Right Of Use Asset RightOfUseAsset	663575	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	46766	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	42131	usd
CY2022Q4	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	599047	usd
CY2021Q4	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	0	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	870551	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	6693224	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2357614	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1997039	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2343654	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1675230	usd
CY2022Q4	fil	Payments In Advance Of Securities Date PaymentsInAdvanceOfSecuritiesDate	217500	usd
CY2021Q4	fil	Payments In Advance Of Securities Date PaymentsInAdvanceOfSecuritiesDate	590020	usd
CY2022Q4	fil	Due To Related Party DueToRelatedParty	503259	usd
CY2021Q4	fil	Due To Related Party DueToRelatedParty	495264	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10978	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	39824	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	3088250	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2219882	usd
CY2022Q4	fil	Current Portion Of Right Of Use Liability CurrentPortionOfRightOfUseLiability	262727	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-12428768	usd
CY2021Q4	fil	Current Portion Of Right Of Use Liability CurrentPortionOfRightOfUseLiability	198869	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	79823	usd
CY2021Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	79823	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8863805	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7295951	usd
CY2022Q4	fil	Right Of Use Liability RightOfUseLiability	200758	usd
CY2021Q4	fil	Right Of Use Liability RightOfUseLiability	475325	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	978337	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1317691	usd
CY2022Q4	us-gaap	Liabilities Liabilities	10042900	usd
CY2021Q4	us-gaap	Liabilities Liabilities	9088967	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37690664	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37690664	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31679481	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31679481	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	37690	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	31679	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49786056	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	46399451	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-58996099	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48833880	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	0	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	7003	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9172349	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2395743	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	870551	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6693224	usd
CY2022	us-gaap	Revenues Revenues	4317490	usd
CY2021	us-gaap	Revenues Revenues	3157783	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	6512109	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	3539636	usd
CY2022	us-gaap	Gross Profit GrossProfit	-2194619	usd
CY2021	us-gaap	Gross Profit GrossProfit	-381853	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3615961	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	9355657	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2641842	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2691258	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	6157802	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	12046915	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-8452422	usd
CY2022	us-gaap	Debt Securities Gain Loss DebtSecuritiesGainLoss	-563220	usd
CY2021	us-gaap	Debt Securities Gain Loss DebtSecuritiesGainLoss	0	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-46516	usd
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-45658	usd
CY2022	us-gaap	Impairment Of Investments ImpairmentOfInvestments	-200000	usd
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-172500	usd
CY2022	fil	Sba Ppp Loan Forgiveness SbaPppLoanForgiveness	0	usd
CY2021	fil	Sba Ppp Loan Forgiveness SbaPppLoanForgiveness	526000	usd
CY2022	us-gaap	Interest Expense InterestExpense	694380	usd
CY2021	us-gaap	Interest Expense InterestExpense	93170	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	113	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	10011	usd
CY2022	us-gaap	Other Income OtherIncome	34206	usd
CY2021	us-gaap	Other Income OtherIncome	0	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1469797	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	224683	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-9922219	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-12204085	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	240000	usd
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	240000	usd
CY2022	fil	Net Loss Available To Common Shareholders NetLossAvailableToCommonShareholders	-10162219	usd
CY2021	fil	Net Loss Available To Common Shareholders NetLossAvailableToCommonShareholders	-12444085	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-19826	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5593	usd
CY2022	fil	Net Loss Available To Cfn Enterprises Common Shareholders NetLossAvailableToCfnEnterprisesCommonShareholders	-10142393	usd
CY2021	fil	Net Loss Available To Cfn Enterprises Common Shareholders NetLossAvailableToCfnEnterprisesCommonShareholders	-12449678	usd
CY2022	fil	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.30
CY2021	fil	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.77
CY2022	fil	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	34258898	shares
CY2021	fil	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	16227143	shares
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1505068	usd
CY2021	fil	Shares Issued As Payment For Accrued Interest Value SharesIssuedAsPaymentForAccruedInterestValue	157500	usd
CY2021	fil	Non Controlling Interest NonControllingInterest	1410	usd
CY2021	fil	Issuance Of Common Stock For Interest Value IssuanceOfCommonStockForInterestValue	170000	usd
CY2021	fil	Shares Issued As Exercise Of Warrant SharesIssuedAsExerciseOfWarrant	50000	usd
CY2021	fil	Payment Of Csis Debt By Shareholder PaymentOfCsisDebtByShareholder	554500	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10620000	usd
CY2021	fil	Shares Issued As For Exercise Of Warrant SharesIssuedAsForExerciseOfWarrant	0	usd
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	240000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-12204085	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2395743	usd
CY2022	fil	Purchase Of Property And Equipment With Common Stock PurchaseOfPropertyAndEquipmentWithCommonStock	700000	usd
CY2022	fil	Increase Decrease In Right Of Use Liability IncreaseDecreaseInRightOfUseLiability	-210709	usd
CY2021	fil	Increase Decrease In Right Of Use Liability IncreaseDecreaseInRightOfUseLiability	-91346	usd
CY2022	fil	Issuance Of Common Stock For Proceeds IssuanceOfCommonStockForProceeds	1050019	usd
CY2022	fil	Shares Issued Pursuant To Conversion Of Debt2 Value SharesIssuedPursuantToConversionOfDebt2Value	1308060	usd
CY2022	fil	Shares Issued As Payment For Accrued Interest Value SharesIssuedAsPaymentForAccruedInterestValue	32000	usd
CY2022	fil	Warrants Issued With Promissory Notes WarrantsIssuedWithPromissoryNotes	302537	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	240000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-9929222	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9172349	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-9922219	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-12204085	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1612332	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	382916	usd
CY2022	fil	Loss On Conversion Of Debt LossOnConversionOfDebt	563220	usd
CY2021	fil	Loss On Conversion Of Debt LossOnConversionOfDebt	0	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	305081	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4437	usd
CY2022	fil	Unrealized Gain Loss On Marketable Securities UnrealizedGainLossOnMarketableSecurities	46516	usd
CY2021	fil	Unrealized Gain Loss On Marketable Securities UnrealizedGainLossOnMarketableSecurities	45660	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3615961	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2022	fil	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	553254	usd
CY2021	fil	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	67461	usd
CY2022	us-gaap	Impairment Of Investments ImpairmentOfInvestments	-200000	usd
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	180398	usd
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2022	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-19826	usd
CY2021	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	1410	usd
CY2022	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	0	usd
CY2021	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	9355657	usd
CY2022	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	0	usd
CY2021	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	526000	usd
CY2022	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	0	usd
CY2021	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	172500	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-66372	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	364694	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-157706	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-488074	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-110365	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-32500	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1266789	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1547899	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-28846	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	14009	usd
CY2022	fil	Payments Made In Advance Of Securities Date PaymentsMadeInAdvanceOfSecuritiesDate	217500	usd
CY2021	fil	Payments Made In Advance Of Securities Date PaymentsMadeInAdvanceOfSecuritiesDate	0	usd
CY2021	fil	Accrual Of Preferred Stock Interest AccrualOfPreferredStockInterest	240000	usd
CY2022	fil	Purchase Of Property And Equipment With Common Stock PurchaseOfPropertyAndEquipmentWithCommonStock	700000	usd
CY2021	fil	Purchase Of Property And Equipment With Common Stock PurchaseOfPropertyAndEquipmentWithCommonStock	0	usd
CY2022	fil	Purchase Of Property And Equipment With Accounts And Notes Payable PurchaseOfPropertyAndEquipmentWithAccountsAndNotesPayable	55016	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1418850	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-344214	usd
CY2022	fil	Purchase Of Property And Equipment Net PurchaseOfPropertyAndEquipmentNet	-339655	usd
CY2021	fil	Purchase Of Property And Equipment Net PurchaseOfPropertyAndEquipmentNet	52543	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	92176	usd
CY2022	fil	Cash Acquired In Acquisition Of Cnp Operating Llc CashAcquiredInAcquisitionOfCnpOperatingLlc	0	usd
CY2021	fil	Cash Acquired In Acquisition Of Cnp Operating Llc CashAcquiredInAcquisitionOfCnpOperatingLlc	62518	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-339655	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	22885	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	7995	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1233000	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	411894	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	49917	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	140651	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	410000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10000	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	50000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1601078	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	331243	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-157427	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	9914	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190029	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	180115	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32602	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190029	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	170015	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	160115	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	20014	usd
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	20000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	190029	usd
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	180115	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12474	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	170015	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	20128	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	20014	usd
CY2022Q4	fil	Cash And Restricted Cash At End Of Period CashAndRestrictedCashAtEndOfPeriod	32602	usd
CY2021Q4	fil	Cash And Restricted Cash At End Of Period CashAndRestrictedCashAtEndOfPeriod	190029	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022	us-gaap	Interest Paid InterestPaid	0	usd
CY2021	us-gaap	Interest Paid InterestPaid	0	usd
CY2022	fil	Accrual Of Preferred Stock Interest AccrualOfPreferredStockInterest	240000	usd
CY2021	fil	Purchase Of Property And Equipment With Accounts And Notes Payable PurchaseOfPropertyAndEquipmentWithAccountsAndNotesPayable	0	usd
CY2022	fil	Settlement Of Accounts Payable With Sale Of Equipment SettlementOfAccountsPayableWithSaleOfEquipment	212067	usd
CY2021	fil	Settlement Of Accounts Payable With Sale Of Equipment SettlementOfAccountsPayableWithSaleOfEquipment	0	usd
CY2022	fil	Warrants Issued With Promissory Notes WarrantsIssuedWithPromissoryNotes	302537	usd
CY2021	fil	Warrants Issued With Promissory Notes WarrantsIssuedWithPromissoryNotes	0	usd
CY2022	fil	Payment Of Csis Debt By Shareholder PaymentOfCsisDebtByShareholder	0	usd
CY2021	fil	Payment Of Csis Debt By Shareholder PaymentOfCsisDebtByShareholder	554500	usd
CY2022	fil	Issuance Of Common Stock Sold In Previous Year IssuanceOfCommonStockSoldInPreviousYear	0	usd
CY2021	fil	Issuance Of Common Stock Sold In Previous Year IssuanceOfCommonStockSoldInPreviousYear	492500	usd
CY2022	fil	Investments Received For Services InvestmentsReceivedForServices	0	usd
CY2021	fil	Investments Received For Services InvestmentsReceivedForServices	92175	usd
CY2022	fil	Issuance Common Stock For Acquisition Of Cnp Operating Llc IssuanceCommonStockForAcquisitionOfCnpOperatingLlc	0	usd
CY2021	fil	Issuance Common Stock For Acquisition Of Cnp Operating Llc IssuanceCommonStockForAcquisitionOfCnpOperatingLlc	10620000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	181134	usd
CY2019Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	3000000	usd
CY2022Q4	fil	Working Capital Deficit WorkingCapitalDeficit	-8802958	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-58996099	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9922219	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"><span style="border-bottom:1px solid #000000">Use of Estimates</span></p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, or GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions about collection of accounts receivable, useful life of fixed assets and intangible assets, impairment of long-lived assets, borrowing rate considered for operating lease right-of-use asset and related operating lease liability, and assumptions used in Black-Scholes valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.</p>
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"><span style="border-bottom:1px solid #000000">Financial Statement Reclassification</span></p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.</p>
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	470532	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	337192	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	180398	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	0	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"><span style="border-bottom:1px solid #000000">Concentration of Credit Risks</span></p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">The Company is subject to concentrations of credit risk primarily from cash and cash equivalents and accounts receivable.</p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">The Company’s cash and cash equivalents accounts are held at a financial institution and are insured by the Federal Deposit Insurance Corporation, or the FDIC, up to $250,000. From time-to-time, the Company’s bank balances exceed the FDIC insurance limit. To reduce its risk associated with the failure of such financial institutions, the Company periodically evaluates the credit quality of the financial institution in which it holds deposits.</p>
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	40243	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	69725	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	9355657	usd
CY2020Q4	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.098	pure
CY2020Q4	us-gaap	Investments Investments	200000	usd
CY2022	us-gaap	Impairment Of Investments ImpairmentOfInvestments	-200000	usd
CY2022Q4	us-gaap	Investments Investments	0	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	3276193	usd
CY2020Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	181134	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	181134	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	64772	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8143937	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11202	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3007941	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	53570	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5135996	usd
CY2022Q2	fil	Purchase Of Property And Equipment With Common Stock PurchaseOfPropertyAndEquipmentWithCommonStock	700000	usd
CY2022	fil	Settlement Of Accounts Payable With Sale Of Equipment SettlementOfAccountsPayableWithSaleOfEquipment	212067	usd
CY2022Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	87933	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	3276193	usd
CY2022	fil	Accumulated Depreciation Reversal AccumulatedDepreciationReversal	4508118	usd
CY2022	us-gaap	Depreciation Depreciation	1612334	usd
CY2021	us-gaap	Depreciation Depreciation	483920	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	46516	usd
CY2022	fil	Additions Of Marketable Securities AdditionsOfMarketableSecurities	0	usd
CY2021	fil	Additions Of Marketable Securities AdditionsOfMarketableSecurities	92175	usd
CY2022	fil	Sale Of Marketable Securities SaleOfMarketableSecurities	0	usd
CY2022	fil	Change In Fair Value Of Marketable Securities ChangeInFairValueOfMarketableSecurities	-46516	usd
CY2021	fil	Change In Fair Value Of Marketable Securities ChangeInFairValueOfMarketableSecurities	-45659	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	46516	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2021Q2	us-gaap	Notes Payable NotesPayable	2957000	usd
CY2021Q2	fil	Outstanding Amount OutstandingAmount	158625	usd
CY2021Q2	fil	Balance Paid Per Month BalancePaidPerMonth	20000	usd
CY2021Q2	fil	Total Paid Per Month TotalPaidPerMonth	138625	usd
CY2022	fil	Purchase Of Property And Equipment With Accounts And Notes Payable PurchaseOfPropertyAndEquipmentWithAccountsAndNotesPayable	55016	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	250000	usd
CY2021Q4	fil	Accrued Interest Rate AccruedInterestRate	0.12	pure
CY2022	fil	Warrants Issued With Promissory Notes WarrantsIssuedWithPromissoryNotes	302537	usd
CY2022	fil	Loss On Conversion LossOnConversion	571220	usd
CY2022	fil	Warrants Issued With Promissory Notes WarrantsIssuedWithPromissoryNotes	302537	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	3088250	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	793585	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	43585	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	27263	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	12507	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	101396	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	4066587	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	3088250	usd
CY2021Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	the Company effected a reverse split of its outstanding common stock in the ratio of 1-for-15
CY2022Q2	fil	Issuance Of Common Stock For Proceeds IssuanceOfCommonStockForProceeds	800020	usd
CY2022Q4	fil	Purchase Of Property And Equipment With Common Stock PurchaseOfPropertyAndEquipmentWithCommonStock	700000	usd
CY2022	fil	Gain On Conversion GainOnConversion	8000	usd
CY2022Q4	fil	Securities Purchase Agreement Shares SecuritiesPurchaseAgreementShares	800000	shares
CY2022Q4	fil	Proceeds From Securities Purchase Agreement ProceedsFromSecuritiesPurchaseAgreement	200000	usd
CY2022Q4	fil	Payments In Advance Of Securities Date PaymentsInAdvanceOfSecuritiesDate	217500	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022	us-gaap	Dividends Paidinkind DividendsPaidinkind	240000	usd
CY2021	us-gaap	Dividends Paidinkind DividendsPaidinkind	240000	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities Current DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent	79823	usd
CY2021Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities Current DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent	79823	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Other Current Liabilities DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities	79823	usd
CY2021Q4	us-gaap	Disposal Group Including Discontinued Operation Other Current Liabilities DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities	79823	usd
CY2022Q4	fil	Assets Held For Sale Long Lived Fair Value Disclosure Gross AssetsHeldForSaleLongLivedFairValueDisclosureGross	700000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	100953	usd
CY2022Q4	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	599047	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Real Estate ProceedsFromSaleOfRealEstate	699000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5666600	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3518643	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-7280948	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7280948	usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.09	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.30	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	2065027	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	1054294	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	21163	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-450679	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-321112	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7280948	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4272988	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7280948	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4272988	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	20300000	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Next Rolling Twelve Months OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths	262727	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Two OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo	234083	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Three OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree	15498	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	512308	usd
CY2022Q4	fil	Imputed Interest ImputedInterest	-48823	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	463485	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	262727	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	200758	usd
CY2022Q4	fil	Right Of Use Asset RightOfUseAsset	110321	usd
CY2021Q4	fil	Right Of Use Asset RightOfUseAsset	663575	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	262727	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	747422	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	200758	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	475325	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	463485	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3221952	usd

Files In Submission

Name	View Source	Status
0001096906-23-000855-index-headers.html	Edgar Link	pending
0001096906-23-000855-index.html	Edgar Link	pending
0001096906-23-000855.txt	Edgar Link	pending
0001096906-23-000855-xbrl.zip	Edgar Link	pending
cfnex10z28_1.jpg	Edgar Link	pending
cfnex10z28_10.jpg	Edgar Link	pending
cfnex10z28_11.jpg	Edgar Link	pending
cfnex10z28_12.jpg	Edgar Link	pending
cfnex10z28_13.jpg	Edgar Link	pending
cfnex10z28_2.jpg	Edgar Link	pending
cfnex10z28_3.jpg	Edgar Link	pending
cfnex10z28_4.jpg	Edgar Link	pending
cfnex10z28_5.jpg	Edgar Link	pending
cfnex10z28_6.jpg	Edgar Link	pending
cfnex10z28_7.jpg	Edgar Link	pending
cfnex10z28_8.jpg	Edgar Link	pending
cfnex10z28_9.jpg	Edgar Link	pending
cfn_ex10z28.htm	Edgar Link	pending
cfn_ex31z1.htm	Edgar Link	pending
cfn_ex32z1.htm	Edgar Link	pending
cnfn-20221231.htm	Edgar Link	pending
cnfn-20221231.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
cnfn-20221231_def.xml	Edgar Link	unprocessable
cnfn-20221231_lab.xml	Edgar Link	unprocessable
cnfn-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cnfn-20221231_htm.xml	Edgar Link	completed
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cnfn-20221231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CNFN
CFN Enterprises Inc. Stock $cnfn

2023 Q2 Form 10-K Financial Statement

#000109690623000855 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNFN CFN Enterprises Inc. Stock $cnfn

2023 Q2 Form 10-K Financial Statement

#000109690623000855 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNFN
CFN Enterprises Inc. Stock $cnfn